Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A Westwood

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Journal of Leukocyte Biology|February 25, 2010
Genetic redirection of T cells for cancer therapyJennifer A Westwood, Michael H Kershaw
Nature Biotechnology|November 5, 2002
Dual-specific T cells combine proliferation and antitumor activityMichael H Kershaw, Jennifer A Westwood, Patrick Hwu
Nature Reviews. Cancer|July 25, 2013
Gene-engineered T cells for cancer therapyMichael H Kershaw, Jennifer A Westwood, Phillip K Darcy
F1000Research|February 21, 2014
Environmental enrichment does not impact on tumor growth in miceJennifer A Westwood, Phillip K Darcy, Michael H Kershaw
Oncoimmunology|January 23, 2015
The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapyJennifer A Westwood, Phillip K Darcy, Michael H Kershaw
Clinical & Translational Immunology|December 16, 2014
Clinical application of genetically modified T cells in cancer therapyMichael H Kershaw, Jennifer A Westwood, Clare Y Slaney, et al.
Oncoimmunology|December 12, 2013
Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironmentMichael H Kershaw, Christel Devaud, Liza B John, et al.
Oncoimmunology|October 2, 2013
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapyChristel Devaud, Liza B John, Jennifer A Westwood, et al.
Immunotherapy|December 23, 2010
Enhancing the specificity of T-cell cultures for adoptive immunotherapy of cancerConnie Pm Duong, Jennifer A Westwood, Linda J Berry, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Cutting edge: TRAIL deficiency accelerates hematological malignanciesNadeen Zerafa, Jennifer A Westwood, Erika Cretney, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Journal of Leukocyte Biology|February 25, 2010
Genetic redirection of T cells for cancer therapyJennifer A Westwood, Michael H Kershaw
Nature Biotechnology|November 5, 2002
Dual-specific T cells combine proliferation and antitumor activityMichael H Kershaw, Jennifer A Westwood, Patrick Hwu
Nature Reviews. Cancer|July 25, 2013
Gene-engineered T cells for cancer therapyMichael H Kershaw, Jennifer A Westwood, Phillip K Darcy
F1000Research|February 21, 2014
Environmental enrichment does not impact on tumor growth in miceJennifer A Westwood, Phillip K Darcy, Michael H Kershaw
Oncoimmunology|January 23, 2015
The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapyJennifer A Westwood, Phillip K Darcy, Michael H Kershaw
Clinical & Translational Immunology|December 16, 2014
Clinical application of genetically modified T cells in cancer therapyMichael H Kershaw, Jennifer A Westwood, Clare Y Slaney, et al.
Oncoimmunology|December 12, 2013
Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironmentMichael H Kershaw, Christel Devaud, Liza B John, et al.
Oncoimmunology|October 2, 2013
Immune modulation of the tumor microenvironment for enhancing cancer immunotherapyChristel Devaud, Liza B John, Jennifer A Westwood, et al.
Immunotherapy|December 23, 2010
Enhancing the specificity of T-cell cultures for adoptive immunotherapy of cancerConnie Pm Duong, Jennifer A Westwood, Linda J Berry, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2005
Cutting edge: TRAIL deficiency accelerates hematological malignanciesNadeen Zerafa, Jennifer A Westwood, Erika Cretney, et al.
Pageof 5